A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Inclusion Criteria: * Patients must be willing and able to complete all study-specific procedures and visits * Healthy patients, as determined by no clinically significant deviation from normal in medical history, physical examination, electrocardiogram, and clinical laboratory determinations * Body mass index (BMI) of 18 to 32 kg/m2, inclusive, at screening * Normal renal function at screening Exclusion Criteria: * Women of childbearing potential not using an effective contraceptive method or are breastfeeding * Any significant acute or chronic medical illness * History of chronic headaches, defined as occurring 15 days or more a month, over the previous 3 months * History of headaches related to caffeine withdrawal, including energy drinks * History of syncope, orthostatic instability, or recurrent dizziness * Active TB requiring treatment or documented latent TB within the previous 3 years Other protocol defined inclusion/exclusion criteria could apply.